Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Canary Insights was a U.S.-based healthcare information management company focused on tracking health plan policy, coverage, and reimbursement changes across the payer and PBM landscape. Its services were used by clients and consultants in pharmaceutical, medical device, laboratory, diagnostics, and healthcare provider/payer markets to monitor access and coverage developments affecting commercial products. The company continuously mined and organized policy changes for hundreds of healthcare-related products, helping customers stay current on evolving reimbursement environments. Founded in 2013 and headquartered in Lakewood, Colorado, Canary Insights was acquired by TrialCard in October 2020; TrialCard later rebranded as Mercalis. Canary Insights appears to have operated as a commercial information-services business rather than a therapeutic drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Canary Insights.